LKQ (LKQ)

$7.4B
Market Cap
12.5
P/E Ratio
0.87
Beta
4.11%
Dividend Yield
Piotroski 4/9Altman Z 2.5 Gray ZoneBeneish M -2.55 CleanROIC−WACC -1.4%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 4/9, Altman Z 2.5.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics of LKQ reveal a capital allocation efficiency where the return on invested capital of 6.7% falls short of typical high-quality thresholds, suggesting limited excess returns relative to risk-free rates. The DuPont decomposition clarifies that equity generation relies heavily on financial leverage at 2.31x rather than operational excellence; while gross margins remain robust at 38.6%, the net margin is compressed to just 4.5% by asset turnover of only 0.90x and declining revenue growth of -1.2%. This structural reliance on debt amplifies sensitivity to interest rate fluctuations, a concern compounded by a Piotroski F-Score of 4/9 indicating moderate financial health, despite the Beneish M-Score of -2.55 offering some reassurance against earnings manipulation risks.

Valuation metrics present a divergence between current market pricing and intrinsic value models derived from discounted cash flow analysis. Trading at a forward P/E of 12.5x, the stock appears compressed relative to historical norms if growth expectations have normalized, yet the DCF model implies a fair value of $26, suggesting the market may be discounting future prospects more aggressively than long-term fundamentals warrant. This gap indicates that investor sentiment is currently pricing in persistent headwinds or lower terminal growth rates than what the cash flow assumptions support, creating a potential mean reversion opportunity contingent on margin expansion or revenue stabilization.

Risk factors remain balanced with no significant insider buying activity over the last 90 days, resulting in neutral institutional positioning as reflected by zero net insider flow. The combination of subpar ROIC and negative revenue trajectory introduces downside volatility that could further depress multiples if operational turnaround fails to materialize quickly. Conversely, the low M-Score provides a floor against accounting fraud risks, though the leverage-heavy DuPont profile means any deterioration in asset quality would disproportionately impact shareholder returns through equity compression rather than organic earnings growth.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6.2%8.2%10.2%
2%$36$21$14
3%$48$26$16
4%$72$33$19

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=8.2%, terminal growth 3%. Fair value $26 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

4/9
Piotroski F-Score
Average — mixed operational signals
2.5
Altman Z-Score
Grey Zone — between 1.8 and 3.0 thresholds. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.55
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

38.6%
Gross Margin
4.5%
Net Margin
6.7%
ROIC
8.2%
WACC
ROIC − WACC Spread: -1.4%— Negative spread.
-1.2%
Revenue Growth (YoY)
-12.0%
Earnings Growth (YoY)
847.0M
Free Cash Flow
37%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

4.5%
Net Profit Margin
NI ÷ Revenue
×
0.90x
Asset Turnover
Revenue ÷ Assets
×
2.31x
Equity Multiplier
Assets ÷ Equity
=
9.3%
Return on Equity
Balanced ROE composition across margins, turnover, and leverage.

Balance Sheet Health

1.31x
Debt / Equity
1.67x
Current Ratio
4.6x
Interest Coverage
2.3x
Net Debt / EBITDA
7.93%
FCF Yield
1.4B
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $0.78
Act: $0.79
+1.5%
Q3
✗ Miss
Est: $0.92
Act: $0.87
-5.8%
Q2
✓ Beat
Est: $0.76
Act: $0.84
+11.0%
Q1
✗ Miss
Est: $0.65
Act: $0.59
-9.3%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

8.7
Forward P/E
PEG Ratio
1.13
Price/Book
3M
Avg Volume
$43.47
52W High
$27.64
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$585M
Tracked Passive Exposure
8
ETFs Holding LKQ
0.11%
Avg Weight in ETFs
$549B
Total ETF AUM

When investors buy or sell ETFs like IJS or SLYV, the fund manager is mechanically forced to buy or sell LKQ shares regardless of LKQ's individual fundamentals. We estimate $585M of passive capital is structurally linked to LKQ through 8 tracked ETFs. Passive flows have a limited but growing influence on LKQ's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in LKQ to visualize passive redemption contagion across ETFs and collateral stocks.

LKQ Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
LKQEpicenterVBETFSPLGETFVYMETFMOHLow RiskEMNMed RiskCAHLow RiskMTCHHigh RiskENPHMed Risk
LKQ Price Drop (%)0

If LKQ (LKQ) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies MOLINA HEALTHCARE INC (MOH) as the most exposed collateral stock, sharing 3 ETFs with LKQ. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 14 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

LKQ Ownership Dynamics

Ticker
LKQ

Float lock-up computed from 13 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

LKQ Capital Efficiency

How efficiently does LKQ convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$847M
EBITDA
$1.4B
FCF Conversion
59%
Reinvestment Rate
41%
59% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
6.7%
ROIC − WACC Spread
-1.4%

LKQ converts 59% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. However, the ROIC-WACC spread is negative (-1.4%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-14103$26.37$2,716.11
2026-05-132,528$26.85$67,876.8
2026-05-1180$28.89$2,311.2
2026-05-053,277$27.75$90,936.75
2026-04-163,012$30.34$91,384.08
2026-04-149,844$30.34$298,666.96
2026-04-082,015$28.81$58,052.15
2026-04-072,025$28.98$58,684.5
2026-03-241,606$28.79$46,236.74
2026-03-2315,032$28.26$424,804.32
2026-03-191,595$28.63$45,664.85
2026-03-171,418$28.72$40,724.96
2026-03-0614$31.46$440.44
2026-03-0338,592$32.78$1.3M
2026-02-2344,338$34.10$1.5M
2026-02-12901$34.80$31,354.8
2026-02-116,282$34.60$217,357.2
2026-02-10536$34.18$18,320.48
2026-02-0925$34.58$864.5
2026-02-0458$32.99$1,913.42
2026-01-262,393$34.04$81,457.72
2026-01-16607$33.93$20,595.51
2026-01-142,729$33.32$90,930.28
2026-01-131,006$33.20$33,399.2
2026-01-121,240$33.40$41,416
2026-01-0817,219$31.21$537,404.99
2025-12-3111,054$30.81$340,573.74
2025-12-309,551$30.55$291,783.05
2025-12-26108$30.26$3,268.08
2025-12-2269,574$29.74$2.1M

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare LKQ to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.